Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | CASR | P41180 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | TBXAS1 | P24557 | 5/20 | 0.47 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.47 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.45 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9618015 | 0.99 | CA1 (0.62) | CA1CA2CASRTDP1L3MBTL1 | |
| SCHEMBL7171686 | 0.86 | PLA2G4B (0.60) | CASRTDP1USP2HTTLPAR5 | |
| SCHEMBL16614396 | 0.85 | L3MBTL1 (0.67) | CA1CA2TDP1L3MBTL1PLA2G4B | |
| SCHEMBL5594970 | 0.84 | CA1 (0.55) | CA1CA2USP2HTTLPAR5 | |
| SCHEMBL13058722 | 0.84 | CA1 (0.55) | CA1CA2USP2HTTLPAR5 | |
| SCHEMBL9662121 | 0.84 | CA1 (0.55) | CA1CA2USP2HTTLPAR5 | |
| SCHEMBL9662170 | 0.84 | CA1 (0.55) | CA1CA2USP2HTTLPAR5 | |
| SCHEMBL9662634 | 0.84 | CA1 (0.55) | CA1CA2USP2HTTLPAR5 | |
| SCHEMBL9716318 | 0.84 | CA1 (0.55) | CA1CA2USP2HTTLPAR5 | |
| SCHEMBL27683549 | 0.84 | CA1 (0.55) | CA1CA2USP2HTTLPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100297156-A1 | ANALOGUES OF PHOSPHATIDYLINOSITOL MANNOSIDES | INDUSTRIAL RESEARCH LIMITED (NZ) | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100297156-A1 | ANALOGUES OF PHOSPHATIDYLINOSITOL MANNOSIDES | PIK3CA, PIK3CB, PIK3CG | CA1 4208/4885CA2 3518/4885CASR 3998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.